SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Willow Lane Acquisition Corp. is a blank check company, which engages for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on July 3, 2024 and is headquartered in New York, NY.

Willow Lane Acquisition Corp. - Ordinary Shares - Class A

WLAC is trending as its de-SPAC merger with AI infrastructure company Boost Run approaches, with a recent S-4 filing signaling an early March completion. The community is enthusiastically highlighting Boost Run's projected high revenue growth and strategic position in the booming AI data center sector, leading to strong bullish sentiment and comparisons to successful peers.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN is surging with community optimism ahead of the 4/20 cultural event, driven by its 'like Bitcoin but way higher' mantra and a vision for global cannabis legalization, fostering a culture of patience and long-term engagement.

Hawaiian Electric Industries, Inc. is a holding company, which engages in electric utility and non-regulated renewable and sustainable infrastructure businesses. The company was founded by C. Dudley Pratt Jr. in 1981 and is headquartered in Honolulu, HI.

Hawaiian Electric Industries, Inc.

Hawaiian Electric Industries is trending as investors react to positive developments surrounding its wildfire-related liabilities, including settlement progress, legislative support, and recent credit rating upgrades. The community is actively discussing a potential long-term recovery and significant institutional accumulation, signaling renewed confidence despite past challenges.

Fartcoin is a meme-driven cryptocurrency where users can submit their best fart jokes or memes to earn initial tokens. Each transaction triggers a hilarious 'Gas Fee' effect, complete with a digital fart sound for maximum comedic impact.

Fartcoin

FARTCOIN is experiencing a surge in trading and community interest following its recent listing on Arkham Exchange, sparking a polarized discussion between those anticipating further parabolic moves as a top memecoin with "utility" and others highlighting its speculative nature. The crypto community is actively monitoring its volatility and reported whale accumulation within the broader memecoin market.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is drawing significant attention as investors anticipate imminent Japan PMDA approval for its Alpha DaRT cancer treatment, alongside groundbreaking pancreatic cancer data and increasing institutional accumulation. The community is overwhelmingly bullish, viewing the company's technology as an undervalued, life-saving breakthrough decoupling from broader market volatility.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad is trending following recent integrations with prediction market platform Kalshi for MON/USDC deposits and the launch of perpetual futures via Orbs, significantly boosting its utility and DeFi capabilities. The community is actively discussing its notable resilience during broader crypto market downturns, seeing it as a "diamond in the rough" Layer 1 blockchain with attractive staking rewards and strong long-term potential.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Abeona Therapeutics is in focus with a notable analyst price target increase, as the community actively discusses the commercial ramp-up of its ZEVASKYN gene therapy, alongside progress in its pipeline and significant institutional interest pointing towards anticipated profitability.

Eaton Corp. Plc is a power management company, which provides energy-efficient solutions for electrical, hydraulic, and mechanical power. It operates through the following segments: Electrical Americas and Electrical Global; Aerospace, Vehicle, and eMobility. The Electrical Americas and Electrical Global segments engage in sales contracts for electrical components, industrial components, power distribution and assemblies, residential products, single and three phase power quality, wiring devices, circuit protection, utility power distribution, power reliability equipment, and service. The Aerospace segment supplies aerospace fuel, hydraulics, and pneumatic systems for commercial and military use. The Vehicle segment deals with the design, manufacture, marketing, and supply of drivetrain and powertrain systems and critical components that reduce emissions and improve fuel economy, stability, performance and safety of cars, light trucks and commercial vehicles. The eMobility segment designs, manufactures, markets, and supplies electrical and electronic components and systems that improve the power management and performance of both on-road and off-road vehicles. The company was founded in 1911 and is headquartered in Dublin, Ireland.

Eaton Corporation plc

Eaton (ETN) is trending as a critical player in the AI infrastructure and electrification supercycle, with recent strategic acquisitions for data center cooling and partnerships with NVIDIA bolstering its position. The community is actively discussing its long-term growth potential in grid modernization, even as some analysts debate its valuation and the sustainability of AI-driven capital expenditure.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending as the market anticipates the imminent signing of a transformative $1.5 billion contract with Applied Digital to power new data centers, reinforcing its position as a critical provider of rapidly deployable energy solutions for the booming AI sector. The community is actively discussing how this, coupled with strategic deleveraging, is setting the stage for a significant re-rating of the stock.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor ($TAO) is drawing significant attention, with the community actively discussing its "Bitcoin of AI" potential and the value of its decentralized AI subnets, amplified by an upcoming halving event and news of a Grayscale ETF filing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Renaissance Group LLC Has $7.57 Million Stock Holdings in ADMA Biologics Inc $ADMA

Renaissance Group LLC boosted its position in ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 50.4% during the 3rd quarter, according to the company in its most recent disclosure with the...

Homestead Advisers Corp Has $2.91 Million Position in ADMA Biologics Inc $ADMA

Homestead Advisers Corp grew its holdings in ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 83.1% in the third quarter, according to the company in its most recent 13F filing with the SEC. The...

Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider

In the closing of the recent trading day, Adma Biologics (ADMA) stood at $17.5, denoting a +1.16% move from the preceding trading day.

ADMA Biologics Inc $ADMA Shares Sold by Lisanti Capital Growth LLC

Lisanti Capital Growth LLC lessened its position in shares of ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 71.1% during the 3rd quarter, according to the company in its most recent 13F filing...

Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?

Based on the average brokerage recommendation (ABR), Adma Biologics (ADMA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

ADMA Biologics Enters Oversold Territory (ADMA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...

Adma Biologics (ADMA) Outpaces Stock Market Gains: What You Should Know

Adma Biologics (ADMA) concluded the recent trading session at $16.96, signifying a +1.37% move from its prior day's close.

ADMA Gains 13.8% in Three Months: More Upside Potential for 2026?

ADMA shares rose 13.8% over three months as demand for Asceniv surged, driving higher 2026 revenues and EBITDA targets amid margin expansion.

Adma Biologics (ADMA) Increases Despite Market Slip: Here's What You Need to Know

Adma Biologics (ADMA) concluded the recent trading session at $17.59, signifying a +1.62% move from its prior day's close.

Campbell & CO Investment Adviser LLC Purchases Shares of 64,535 ADMA Biologics Inc $ADMA

Campbell & CO Investment Adviser LLC acquired a new stake in ADMA Biologics Inc (NASDAQ:ADMA - Free Report) during the 3rd quarter, according to its most recent filing with the Securities & Exchange...

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Stocktwits Polls

With crypto and tech experiencing a significant downturn, investors are considering ADMA as a resilient biotech alternative unaffected by AI.

ADMA
Adma Biologics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ADMA News

ADMAAdma Biologics Inc